Provided by Tiger Trade Technology Pte. Ltd.

Doximity, Inc.

24.41
-0.3900-1.57%
Pre-market: 25.060.6500+2.66%07:32 EDT
Volume:5.11M
Turnover:125.05M
Market Cap:4.51B
PE:20.52
High:24.95
Open:24.69
Low:24.24
Close:24.80
52wk High:76.51
52wk Low:23.53
Shares:184.71M
Float Shares:133.13M
Volume Ratio:2.43
T/O Rate:3.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.19
EPS(LYR):1.11
ROE:23.82%
ROA:12.84%
PB:4.60
PE(LYR):21.99

Loading ...

Doximity Initiated at Buy by Freedom Capital Markets

Dow Jones
·
Mar 18

Analysts Offer Insights on Healthcare Companies: Canopy Growth (CGC) and Doximity (DOCS)

TIPRANKS
·
Mar 18

Doximity initiated with a Buy at Freedom Capital

TIPRANKS
·
Mar 18

Doximity report finds 54% of physicians use AI and 71% cite accuracy concerns

Reuters
·
Mar 17

Dr. Martens Executives Increase Stakes via Share Incentive Plan

TIPRANKS
·
Mar 13

Doximity's Early 2026 Portal Activity Points to Steady Demand, RBC Says

MT Newswires Live
·
Mar 10

Doximity Price Target Maintained With a $44.00/Share by RBC Capital

Dow Jones
·
Mar 09

Doximity Director Kira Scherer Wampler Disposes of Common Shares

Reuters
·
Mar 06

Dr. Martens Confirms Total Voting Share Capital for FCA Disclosure

TIPRANKS
·
Feb 27

Is It Time To Reassess Doximity (DOCS) After Its 65% One Year Share Price Slide

Simply Wall St.
·
Feb 24

Doximity Is Maintained at Neutral by JP Morgan

Dow Jones
·
Feb 21

Doximity Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Feb 20

U.S. RESEARCH ROUNDUP-Dropbox, Etsy, Zscaler

Reuters
·
Feb 20

Doximity Inc. Files Initial Statement of Beneficial Ownership for Interim PFO and PAO Siddharth Sitaram

Reuters
·
Feb 14

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), Doximity (DOCS) and Humana (HUM)

TIPRANKS
·
Feb 12

Doximity Is Maintained at Overweight by Barclays

Dow Jones
·
Feb 11

Doximity Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
Feb 10

Canaccord Genuity Upgrades Doximity to Buy From Hold, Adjusts Price Target to $34 From $48

MT Newswires Live
·
Feb 09

Doximity upgraded to Buy from Hold at Canaccord

TIPRANKS
·
Feb 09

Doximity: Network Effects, Normalizing Pharma Budgets, and Undemanding Valuation Create an Attractive Buy Opportunity

TIPRANKS
·
Feb 09